CHMP Recommends Scemblix for Newly Diagnosed CML in Europe, Offering Superior Efficacy and Tolerability Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the…
Agenus Reports Durable Two-Year Survival with BOT/BAL Combination Across Refractory Solid Tumors at ESMO 2025 Agenus Inc. (Nasdaq: AGEN), a biotechnology company recognized for its pioneering work in immuno-oncology, unveiled highly encouraging new clinical data from its novel combination therapy…
Roche Unveils Promising Phase III Data for Vamikibart in Uveitic Macular Edema (UME), Highlighting Potential as First-in-Class Non-Steroidal Treatment Option Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced pivotal Phase III results from two large-scale clinical studies — MEERKAT and…
Roquette Opens State-of-the-Art Pharmaceutical Innovation Center in São Paulo to Drive Latin American Healthcare Solutions Roquette, a global leader in plant-based ingredients and pharmaceutical excipients serving the health, nutrition, and bio-industrial markets, today announced the grand opening of its dedicated…
EMD Serono Partners with U.S. Government to Expand Access to IVF Therapies for Millions of Americans EMD Serono, the healthcare division of Merck KGaA, Darmstadt, Germany, operating in the United States and Canada, has announced a groundbreaking agreement with the…
Revolution Medicines Receives FDA Priority Voucher for Daraxonrasib (RMC-6236) Under Commissioner’s National Priority Voucher Pilot Program Revolution Medicines Receives FDA Priority Voucher for Daraxonrasib (RMC-6236) Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company pioneering the development of targeted therapies…
Grifols Strengthens U.S. Diagnostic Manufacturing with New San Diego Facility Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global healthcare company specializing in plasma-derived medicines and innovative diagnostic solutions, has officially commenced production at its newly inaugurated facility in…
Taiho Pharma and Haihe Biopharma Form Exclusive Japanese Partnership for PI3Kα Inhibitor Risovalisib Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Haihe Biopharma Co., Ltd. (“Haihe”) today announced the signing of an exclusive license agreement for the development, manufacturing, and commercialization of…
Veradermics Secures $150M Series C to Advance Oral Hair Regrowth Therapy Connecticut-based biotech Veradermics has raised $150 million in an oversubscribed Series C funding round to advance its oral hair regrowth therapy, VDPHL01, through late-stage clinical development and regulatory submission.…
CVS Health Expands Access to Affordable Fertility Treatments Nationwide CVS Health (NYSE: CVS) has announced a major step toward improving access to fertility care and making fertility treatments more affordable for Americans. Through its CVS Specialty Pharmacy network and more…
Merck’s Phase 3 KEYNOTE-B96 Trial Achieves Key Milestone in Platinum-Resistant Ovarian Cancer, Demonstrating Survival Benefit in All-Comer Population Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that its pivotal Phase 3 KEYNOTE-B96 (ENGOT-ov65) clinical…
Digitail and CDMV Partner to Streamline Veterinary Operations and Improve Patient Care Across Canada Digitail, the industry’s leading AI-native veterinary practice information management system (PIMS), has announced a strategic integration and go-to-market partnership with CDMV, Canada’s premier distributor and service…
